H.R. 1776 - Improving Access To Affordable Prescription Drugs Act
- Sponsor:
- Janice D. Schakowsky
- Summary:
- To improve access to affordable prescription drugs. (by CRS)
- Status:
- The bill has been referred to committee.
Improving Access To Affordable Prescription Drugs Act
H.R. 1776 — 115th Congress (2017–2018)
- Summary
- To improve access to affordable prescription drugs. (by CRS)
- Learn More
- At OpenCongress
- Title
- To improve access to affordable prescription drugs.
- Other Titles
- Improving Access To Affordable Prescription Drugs Act
- Improving Access To Affordable Prescription Drugs Act
- Improving Access To Affordable Prescription Drugs Act
- Sponsor
- Janice D. Schakowsky
- Co-Sponsors
- Nanette Diaz Barragán
- Judy Chu
- Steve Cohen
- John Conyers, Jr.
- Elijah E. Cummings
- Peter A. DeFazio
- Rosa L. DeLauro
- Keith Ellison
- Raúl M. Grijalva
- Pramila Jayapal
- Ro Khanna
- Sean Patrick Maloney
- Betty McCollum
- Richard M. Nolan
- Eleanor Holmes Norton
- Collin C. Peterson
- Chellie Pingree
- Mark Pocan
- Bobby L. Rush
- Tim Ryan
- Carol Shea-Porter
- Peter J. Visclosky
- Peter Welch
- Subjects
- Health
- Administrative law and regulatory procedures
- Administrative remedies
- Business records
- Canada
- Cancer
- Civil actions and liability
- Competition and antitrust
- Congressional oversight
- Consumer affairs
- Corporate finance and management
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Executive agency funding and structure
- Federal Trade Commission (FTC)
- Government information and archives
- Government studies and investigations
- Government trust funds
- Health care costs and insurance
- Health care coverage and access
- Health programs administration and funding
- Income tax deductions
- Infectious and parasitic diseases
- Inflation and prices
- Judicial review and appeals
- Licensing and registrations
- Marketing and advertising
- Medicaid
- Medical research
- Medicare
- National Institutes of Health (NIH)
- Prescription drugs
- Public contracts and procurement
- Research and development
- Retail and wholesale trades
- Trade restrictions
- User charges and fees
- Veterans' medical care
- Related Bills
- H.R. 6340 (115th) : Capping Prescription Costs Act of 2018
- S. 252 (115th) : Medicare Drug Savings Act of 2017
- S. 348 (115th) : Prescription Drug and Health Improvement Act of 2017
- S. 469 (115th) : Affordable and Safe Prescription Drug Importation Act
- S. 3411 (115th) : Affordable Medications Act
- S. 2478 (115th) : End Taxpayer Subsidies for Drug Ads Act
- S. 771 (115th) : Improving Access To Affordable Prescription Drugs Act
- H.R. 1245 (115th) : Affordable and Safe Prescription Drug Importation Act
- S. 2476 (115th) : Expanding Access to Low Cost Generic Drugs Act
- S. 1688 (115th) : Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
- Major Actions
Introduced 3/29/2017 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/29/2017 3/29/2017 Introduced in House 3/29/2017 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 3/31/2017 Referred to the Subcommittee on Health. 4/05/2017 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
Contributions data source: OpenSecrets.org